If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
181.90    -1.70 (-0.93%)
Bid:
181.30
Ask:
181.90
Spread: 0.60 (0.331%)
Market Cap: £801.93m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Director/PDMR Shareholding

29 Sep 2017 07:28

RNS Number : 2074S
Pets At Home Group Plc
29 September 2017
 

29 September 2017

Notification of Transaction of PDMR

 

Pets at Home Group Plc

 

Pets at Home Group Plc ("the Company") makes the following announcement regarding one of its Persons Discharging Managerial Responsibility's (PDMR) participation in the Company's Sharesave Plan ("Sharesave")

 

The Sharesave Plan is a tax advantaged share option plan available to all of the Company's employees, subject to qualifying conditions. It offers the opportunity for employees to buy ordinary shares of 1 pence each ("Share") in the Company using savings accumulated over a three year period.

 

The PDMR detailed below has elected to cancel his participation in the 2016 offer of Sharesave, resulting in the lapsing of the options originally granted to him on 11th October 2016 with an exercise price of £1.97 per Share. The options would have become exercisable on 1st December 2019. 4,550 options lapsed. The notification of dealing form for the PDMR can be found below.

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Peter Pritchard

2

Reason for the notification

 

a)

Position/status

Chief Executive of the Retail Division

 

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pets at Home Group Plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

 

Identification code

Options over Ordinary shares of 1 pence each in Pets at Home Group Plc

 

 

ISIN GB00BJ62K685

b)

Nature of the Transaction

Peter Pritchard cancelled his participation in the 2016 offer under the Pets at Home Group Sharesave Scheme and discontinued his monthly contributions resulting in the lapsing of the Options originally granted to him on the 11th October 2016 with an exercise price of £1.97 per Share. The Sharesave is a tax advantaged share scheme offered to all eligible employees of the Company.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

£1.97

4,550

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

Price

 

Aggregated volume

Aggregate Total

£1.97 per Share

4,550

£8,963.50

e)

Date of Transaction

28th September 2017

f)

Place of Transaction

London Stock Exchange (XLON)

 

This announcement is made in accordance with Article 19 of the Market Abuse Regulation and the Disclosure and Transparency Rules.

 

 

Persons responsible for arranging the release of this announcement

 

Louise Stonier

Group Legal Director and Company Secretary

Pets at Home Group Plc

Epsom Avenue

Stanley Green Trading Estate

Handforth

Cheshire

SK9 3RN

Tel: 0161 486 3590

Email: companysecretary@petsathome.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKCDBABKKOCB
Date   Source Headline
22nd Jan 201912:52 pmRNSHolding(s) in Company
22nd Jan 20197:00 amRNSTrading Statement
17th Jan 20197:00 amRNSHolding(s) in Company
10th Jan 20195:16 pmRNSHolding(s) in Company
9th Jan 20195:17 pmRNSHolding(s) in Company
20th Dec 20187:00 amRNSExecutive Management Team Appointment
19th Dec 20185:20 pmRNSHolding(s) in Company
27th Nov 20187:00 amRNSInterim Financial Results
1st Nov 20187:00 amRNSExecutive Management Team Appointments
15th Oct 201811:21 amRNSChange in Director's details
12th Oct 201811:37 amRNSDirector/PDMR Shareholding
12th Oct 201811:37 amRNSDirector/PDMR Shareholding
12th Oct 201811:37 amRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSExecutive Management Team Changes
9th Oct 201812:54 pmRNSHolding(s) in Company
5th Oct 20182:37 pmRNSHolding(s) in Company
3rd Oct 20187:00 amRNSSegmental Reporting Information
1st Oct 201812:34 pmRNSDirector/PDMR Shareholding
14th Sep 20184:01 pmRNSDirector/PDMR Shareholding
3rd Aug 20187:00 amRNSQ1 Trading Statement
2nd Aug 20182:48 pmRNSHolding(s) in Company
19th Jul 201812:05 pmRNSDirector/PDMR Shareholding
12th Jul 20182:54 pmRNSResult of AGM
6th Jul 20187:09 amRNSHolding(s) in Company
6th Jul 20187:06 amRNSHolding(s) in Company
6th Jul 20187:00 amRNSHolding(s) in Company
5th Jul 201812:10 pmRNSHolding(s) in Company
4th Jul 20184:01 pmRNSHolding(s) in Company - Replacement
2nd Jul 20185:32 pmRNSHolding(s) in Company
2nd Jul 20185:31 pmRNSHolding(s) in Company
25th Jun 20182:37 pmRNSHolding(s) in Company
22nd Jun 20187:00 amRNSHolding(s) in Company
21st Jun 20184:09 pmRNSHolding(s) in Company
19th Jun 20182:02 pmRNSDirector/PDMR Shareholding
18th Jun 20186:11 pmRNSHolding(s) in Company
18th Jun 20186:11 pmRNSHolding(s) in Company
18th Jun 20182:15 pmRNSHolding(s) in Company
15th Jun 20185:33 pmRNSHolding(s) in Company
15th Jun 20182:04 pmRNSHolding(s) in Company
15th Jun 20187:07 amRNSHolding(s) in Company
15th Jun 20187:06 amRNSHolding(s) in Company
12th Jun 20183:14 pmRNSDirector/PDMR Shareholding
8th Jun 20184:29 pmRNSNotice of AGM
8th Jun 201812:30 pmRNSDirector/PDMR Shareholding
8th Jun 201812:28 pmRNSDirector/PDMR Shareholding
8th Jun 201812:27 pmRNSDirector/PDMR Shareholding
24th May 201811:27 amRNSDirector/PDMR Shareholding
24th May 201811:26 amRNSDirector/PDMR Shareholding
24th May 201811:25 amRNSDirector/PDMR Shareholding
24th May 201811:23 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.